Yochi Hagay - Bioharvest Sciences CTO CoFounder
| CNVCFDelisted Stock | USD 5.13 0.07 1.35% |
Insider
Yochi Hagay is CTO CoFounder of Bioharvest Sciences
| Age | 64 |
| Phone | 604 622 1186 |
| Web | https://www.bioharvest.com |
Bioharvest Sciences Management Efficiency
The company has return on total asset (ROA) of (0.5264) % which means that it has lost $0.5264 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (63.6438) %, meaning that it generated substantial loss on money invested by shareholders. Bioharvest Sciences' management efficiency ratios could be used to measure how well Bioharvest Sciences manages its routine affairs as well as how well it operates its assets and liabilities.Bioharvest Sciences has accumulated 3.97 M in total debt with debt to equity ratio (D/E) of 1.62, which is about average as compared to similar companies. Bioharvest Sciences has a current ratio of 0.68, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Bioharvest Sciences until it has trouble settling it off, either with new capital or with free cash flow. So, Bioharvest Sciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bioharvest Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bioharvest to invest in growth at high rates of return. When we think about Bioharvest Sciences' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Andrew Judd | Laird Superfood | N/A | |
| Jane Xu | The A2 Milk | N/A | |
| Martin Huber | Aryzta AG PK | 53 | |
| Catherine Makin | Avi Ltd ADR | 59 | |
| Jamie Eichman | Laird Superfood | 46 | |
| David Akers | The A2 Milk | N/A | |
| Richard Martin | Premier Foods Plc | N/A | |
| Rhona Shakespeare | Aryzta AG PK | 49 | |
| Marcus Opitz | Aryzta AG PK | 62 | |
| Laird Hamilton | Laird Superfood | 60 | |
| Justin OMeara | Avi Ltd ADR | 45 | |
| Urs Jordi | Aryzta AG PK | 58 | |
| Richard Kaiser | BioForce Nanosciences Holdings | 57 | |
| John LaViolette | BioForce Nanosciences Holdings | 62 | |
| Gabrielle Reece | Laird Superfood | N/A | |
| Paul Thompson | Premier Foods Plc | N/A | |
| Simon BBusSci | Avi Ltd ADR | 60 | |
| Alexander Whitehouse | Premier Foods Plc | N/A | |
| Amanda Hart | The A2 Milk | N/A | |
| Keith Cooper | Aryzta AG PK | N/A | |
| Ronan Minahan | Aryzta AG PK | N/A | |
Management Performance
| Return On Equity | -63.64 | |||
| Return On Asset | -0.53 |
Bioharvest Sciences Leadership Team
Elected by the shareholders, the Bioharvest Sciences' board of directors comprises two types of representatives: Bioharvest Sciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bioharvest. The board's role is to monitor Bioharvest Sciences' management team and ensure that shareholders' interests are well served. Bioharvest Sciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bioharvest Sciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Zaki Rakib, CoFounder Chairman | ||
| BCom BComm, Chief Officer | ||
| Brian Cornblatt, Chief Officer | ||
| David Ryan, S Relations | ||
| Yochi Hagay, CTO CoFounder | ||
| Ilan Sobel, Chief Officer |
Bioharvest Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Bioharvest Sciences a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -63.64 | |||
| Return On Asset | -0.53 | |||
| Profit Margin | (2.69) % | |||
| Operating Margin | (2.45) % | |||
| Current Valuation | 106.97 M | |||
| Shares Outstanding | 460.72 M | |||
| Shares Owned By Insiders | 35.15 % | |||
| Price To Book | 91.96 X | |||
| Price To Sales | 28.13 X | |||
| Revenue | 2.1 M |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Bioharvest Sciences information on this page should be used as a complementary analysis to other Bioharvest Sciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Consideration for investing in Bioharvest OTC Stock
If you are still planning to invest in Bioharvest Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bioharvest Sciences' history and understand the potential risks before investing.
| CEOs Directory Screen CEOs from public companies around the world | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |